Evolva(瑞士)
Evolva SA
瑞士EvolvaSA www.evolva.com瑞士生物科技公司Evolva是一家研發(fā)治療動脈血栓形成以及真菌感染的公司。而諾華投資(NovartisVenture)阿拉維(Aravis),太陽石資本(SunstoneCapita)以及丹麥創(chuàng)新資本集團(DanskInnovations)都是其投資者之一。Evolvawasfoundedin2004aroundadistinctive,propr
ietary,technologyplatformthatusessyntheticbiologytocreateinnovativesmallmoleculedrugsandothercompounds.Inparticularourplatformallowsthecreationofchemistriesthatrecapitulatethethemesfoundinnaturalproducts,butwithoutthedisadvantagesofthoseapproaches.Wehaveusedthisplatformacrossarangeofpharmaceuticalandrelatedapplicationsandhavecreatedapipelineofstronglydifferentiatedcompoundsthataddressmajorunmetmedicalneeds.Ourcompoundsareorallyavailable,potentandcovernewstructuralclassesand/ornewmechanisms.Ourthreemostimportantcompoundsare:EV-077forrenaldiseaseandarterialthrombosis.EV-077isinPhaseIEV-086forfungalinfections.EV-086is